Pfizer Covid vaccine for young children may not be renewed by FDA

Email obtained by Guardian says Pfizer was told approval may not be granted, meaning Moderna may have to fill gap

Pfizer’s Covid vaccine for young children may not be renewed by the US Food and Drug Administration (FDA) this fall, prompting Moderna to fill possible gaps in supply, according to an email obtained by the Guardian.

The move would pull the only remaining Covid vaccine for all children under five from the market.

The Moderna vaccine is only approved for children with one or more health conditions, and the pediatric Covid vaccine from Novavax is only available for children aged 12 and up with health conditions.

“It certainly would create a hole in the availability of vaccines,” said Georges Benjamin, executive director of the American Public Health Association.